Archive for September, 2004

h1

109657250700262752

September 30, 2004

FDA Eases Rules on Drug Manufacturing
“Drug makers will not need regulatory approval for every change in their manufacturing processes under new guidelines designed to prevent supply disruptions, U.S. health officials said on Wednesday.

The modification is part of a just-completed, two-year effort to overhaul regulation of pharmaceutical manufacturing, a major issue for drug makers. “

Advertisements
h1

109639323584932930

September 28, 2004

Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving its search for new drugs “

h1

109639312848942644

September 28, 2004

“It’s a Perfect Storm” for Drugmakers
“Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving its search for new drugs “

h1

109631405321848151

September 27, 2004

Long Trip for Psychedelic Drugs
“Psychedelic drugs are inching their way slowly but surely toward prescription status in the United States, thanks to a group of persistent scientists who believe drugs like ecstasy and psilocybin can help people with terminal cancer, obsessive-compulsive disorder and post-traumatic stress disorder, to name just a few. “

h1

109579722645843119

September 21, 2004

Genetically altered grass spreads like wildfire
“A new study shows that genes from genetically engineered grass can spread much farther than previously known, a finding that raises questions about the straying of other plants altered through biotechnology. That could hurt the efforts of two companies to win approval for the first bioengineered grass”

h1

109561890698049510

September 19, 2004

How Dublin Keeps Big Pharma Happy
“It’s moving from basic manufacturing to sophisticated R&D to fend off rivals”

h1

109464974592812967

September 8, 2004

The Trials of ImClone
“A founder in handcuffs, financials in disarray, and a vital product in doubt-for CEO Daniel Lynch, it was the turnaround from hell.”